367 related articles for article (PubMed ID: 15007246)
1. Adjuvant chemoradiotherapy in gastric cancer and carcinoma of the oesophago-gastric junction.
Stahl M
Onkologie; 2004 Feb; 27(1):33-6. PubMed ID: 15007246
[TBL] [Abstract][Full Text] [Related]
2. Preoperative and adjuvant therapies for upper gastrointestinal cancers.
Varadhachary G; Ajani JA
Expert Rev Anticancer Ther; 2005 Aug; 5(4):719-25. PubMed ID: 16111471
[TBL] [Abstract][Full Text] [Related]
3. Individualized surgical strategies for cancer of the esophagogastric junction.
Stein HJ; Feith M; Siewert JR
Ann Chir Gynaecol; 2000; 89(3):191-8. PubMed ID: 11079787
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of adjuvant chemoradiotherapy after a radical gastrectomy and a D2 node dissection for gastric adenocarcinoma.
Leong CN; Chung HT; Lee KM; Shakespeare TP; Mukherjee RK; Wong LC; Lu JJ; Tey J; Lim R; So JB; Back MF
Cancer J; 2008; 14(4):269-75. PubMed ID: 18677137
[TBL] [Abstract][Full Text] [Related]
5. Cancer of the gastroesophageal junction: combined modality therapy.
Ilson DH
Surg Oncol Clin N Am; 2006 Oct; 15(4):803-24. PubMed ID: 17030275
[TBL] [Abstract][Full Text] [Related]
6. Intraoperative radiotherapy combined with adjuvant chemoradiotherapy for locally advanced gastric adenocarcinoma.
Fu S; Lu JJ; Zhang Q; Yang Z; Peng L; Xiong F
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1488-94. PubMed ID: 18538489
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant therapy in gastric cancer.
Lim L; Michael M; Mann GB; Leong T
J Clin Oncol; 2005 Sep; 23(25):6220-32. PubMed ID: 16135489
[TBL] [Abstract][Full Text] [Related]
8. An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach.
Kim S; Lim DH; Lee J; Kang WK; MacDonald JS; Park CH; Park SH; Lee SH; Kim K; Park JO; Kim WS; Jung CW; Park YS; Im YH; Sohn TS; Noh JH; Heo JS; Kim YI; Park CK; Park K
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1279-85. PubMed ID: 16099596
[TBL] [Abstract][Full Text] [Related]
9. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
[TBL] [Abstract][Full Text] [Related]
10. Role of post-operative chemoradiation in resected gastric cancer.
Macdonald JS
J Surg Oncol; 2005 Jun; 90(3):166-70. PubMed ID: 15895449
[TBL] [Abstract][Full Text] [Related]
11. Resection for gastric cancer in the community.
van de Velde CJ
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441
[TBL] [Abstract][Full Text] [Related]
12. [Adjuvant therapy concepts in advanced stomach carcinoma. Future treatment not without irradiation?].
Schendera A; Seegenschmiedt MH
MMW Fortschr Med; 2003 Nov; 145(48):36-8. PubMed ID: 14724997
[TBL] [Abstract][Full Text] [Related]
13. Evolving role of chemoradiation in the adjuvant treatment of gastric cancer.
Leong T
Expert Rev Anticancer Ther; 2004 Aug; 4(4):585-94. PubMed ID: 15270662
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant chemoradiotherapy in patients with stage III or IV radically resected gastric cancer: a pilot study.
Orditura M; De Vita F; Muto P; Vitiello F; Murino P; Lieto E; Vecchione L; Romano A; Martinelli E; Renda A; Ferraraccio F; Del Genio A; Ciardiello F; Galizia G
Arch Surg; 2010 Mar; 145(3):233-8. PubMed ID: 20231623
[TBL] [Abstract][Full Text] [Related]
15. Selecting a specific pre- or postoperative adjuvant therapy for individual patients with operable gastric cancer.
Briasoulis E; Liakakos T; Dova L; Fatouros M; Tsekeris P; Roukos DH; Kappas AM
Expert Rev Anticancer Ther; 2006 Jun; 6(6):931-9. PubMed ID: 16761937
[TBL] [Abstract][Full Text] [Related]
16. [Clinical practice guidelines: 2004 Standards, Options and Recommendations for the management of patient with adenocarcinoma of the stomach--radiotherapy].
Ychou M; Gory-Delabaere G; Blanc P; Bosquet L; Duffour J; Giovannini M; Guillemin F; Lemanski C; Marchal F; Masson B; Merrouche Y; Monges G; Adenis A; Bosset JF; Bouché O; Conroy T; Pezet D; Triboulet JP; ; ;
Cancer Radiother; 2004 Oct; 8(5):322-35. PubMed ID: 15561598
[TBL] [Abstract][Full Text] [Related]
17. Surgery in oesophago-gastric cancer with metastatic disease: Treatment, prognosis and preoperative patient selection.
Schmidt T; Alldinger I; Blank S; Klose J; Springfeld C; Dreikhausen L; Weichert W; Grenacher L; Bruckner T; Lordick F; Ulrich A; Büchler MW; Ott K
Eur J Surg Oncol; 2015 Oct; 41(10):1340-7. PubMed ID: 26213358
[TBL] [Abstract][Full Text] [Related]
18. (18)F-FDG PET-guided salvage neoadjuvant radiochemotherapy of adenocarcinoma of the esophagogastric junction: the MUNICON II trial.
zum Büschenfelde CM; Herrmann K; Schuster T; Geinitz H; Langer R; Becker K; Ott K; Ebert M; Zimmermann F; Friess H; Schwaiger M; Peschel C; Lordick F; Krause BJ
J Nucl Med; 2011 Aug; 52(8):1189-96. PubMed ID: 21764790
[TBL] [Abstract][Full Text] [Related]
19. [Clinical and pathological prognostic factors for cancers of the esophagogastric junction].
Schmidt SC; Schlechtweg N; Veltzke-Schlieker W; Thuss-Patience P; Pratschke J; Neuhaus P; Schumacher G
Zentralbl Chir; 2009 Sep; 134(5):455-61. PubMed ID: 19757346
[TBL] [Abstract][Full Text] [Related]
20. Postoperative intraperitoneal 5-fluoro-2'-deoxyuridine added to chemoradiation in patients curatively resected (R0) for locally advanced gastric and gastroesophageal junction adenocarcinoma.
Cohen DJ; Newman E; Iqbal S; Chang RY; Potmesil M; Ryan T; Donahue B; Chandra A; Liu M; Utate M; Hiotis S; Pachter LH; Hochster H; Muggia F
Ann Surg Oncol; 2012 Feb; 19(2):478-85. PubMed ID: 21769462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
